Rehn M, Chia V, Younan D, Hooda N, Fryzek J, Suh M, Mezzi K, Soeda J. 2024. An updated systematic literature review of safety and efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus Bevacizumab in adult patients with RAS wild-type left-sided metastatic colorectal cancer. PROSPERO 2024:CRD42022338784. Available from: https://www.crd.york.ac.uk/PROSPERO/view/CRD42022338784.